Registered entities
BLUEJAY THERAPEUTICS INC
Reg. No. 844654221United States
Bluejay Therapeutics Inc.
Reg. No. 84-4654221United States
Innovation
4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 16 times.
| Year | Filings |
|---|---|
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Social engagement
Social engagement: 4.5K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; lead investors include Arkin Holdings, Frazier Life Sciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 2 | 13% |
| Other / undisclosed | 5 | 33% |
Recent activity
19 Nov 2025
Event
Scaling up hepatitis delta testing: Breaking barriers, seizing opportunities
12 Nov 2025
Event
The World Hepatitis Alliance webinar on scaling up hepatitis delta testing
7 Nov 2025
Event
The Liver Meeting